Work

Pricing of First and Second Generation Tyrosine Kinase Inhibitors (TKIs) Pre- and Post-Transition of Imatinib to Generic Status

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-123490

Authors: Kelly Kenzik, Ravi Bhatia, Smita Bhatia

Institution: University of Alabama at Birmingham

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2987659505

Cites:

Cited by:

Related to: 10